Finoriq research workspace
BullFrog AI Holdings, Inc. (BFRG) SEC Filings & Filing Highlights
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on. Review BFRG SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
- Company
- BullFrog AI Holdings, Inc. (BFRG)
- Ticker
- BFRG
- Market Cap
- $11.8M
- Latest Price
- $0.6382
- Industry
- Biotech & Pharma
BullFrog AI Holdings, Inc. (BFRG) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BullFrog AI Holdings, Inc. (BFRG).
| Event | Form | Date |
|---|---|---|
| On June 11, 2026, the Company held its 2026 Annual Meeting of Stockholders. A total of 7,794,16...On June 11, 2026, the Company held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 7,794,169 shares were present... | 8-K5.07 | 2026-06-15 |
| On June 11, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of Bul...On June 11, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of BullFrog AI Holdings, Inc. (the “Company”) appr... | 8-K5.02 | 2026-06-15 |
| BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity RequirementBullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement | 8-K8.01 | 2026-04-22 |
| BullFrog AI Holdings, Inc.: Shareholder nominationOn April 15, 2026, the Board of Directors of BullFrog AI Holdings, Inc. (the “Company”) established June 11, 2026 as the date of the Compan... | 8-K5.08 | 2026-04-21 |
| First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipelin...BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity w... | 8-K8.01 | 2026-04-13 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.